CA125 in the monitoring of response to chemotherapy of ovarian carcinoma

M. Quaranta; V. Lorusso; M. Coviello; G. Micelli; A. Casamassima

CA125 in the monitoring of response to chemotherapy of ovarian carcinoma

M. Quaranta, V. Lorusso, M. Coviello, G. Micelli, A. Casamassima

IRCCS Giovanni Paolo II

Research output: Contribution to journal › Article › peer-review

Abstract

CA125 serum levels were assessed in 23 patients undergoing chemotherapy for advanced epithelial ovarian carcinoma (EOC). Rising, falling and unchanged levels correlated with disease in 21 out of 23 (95%) cases. Ten out of 11 patients who showed objective response to chemotherapy had a decrease in antigen levels. Two out of 3 patients with stable disease had unchanged values. Progression was always associated with rising levels. CA125 is a reliable marker for monitoring response to chemotherapy in advanced epithelial ovarian carcinoma.

Original language	English
Pages (from-to)	68-70
Number of pages	3
Journal	International Journal of Cancer
Volume	42
Issue number	SUPPL. 3
Publication status	Published - 1988

ASJC Scopus subject areas

Cancer Research
Oncology

Fingerprint Dive into the research topics of 'CA125 in the monitoring of response to chemotherapy of ovarian carcinoma'. Together they form a unique fingerprint.

Cite this

@article{062c4ba9dab34a5f8a57d463e7598f59,

title = "CA125 in the monitoring of response to chemotherapy of ovarian carcinoma",

abstract = "CA125 serum levels were assessed in 23 patients undergoing chemotherapy for advanced epithelial ovarian carcinoma (EOC). Rising, falling and unchanged levels correlated with disease in 21 out of 23 (95%) cases. Ten out of 11 patients who showed objective response to chemotherapy had a decrease in antigen levels. Two out of 3 patients with stable disease had unchanged values. Progression was always associated with rising levels. CA125 is a reliable marker for monitoring response to chemotherapy in advanced epithelial ovarian carcinoma.",

author = "M. Quaranta and V. Lorusso and M. Coviello and G. Micelli and A. Casamassima",

year = "1988",

language = "English",

volume = "42",

pages = "68--70",

journal = "International Journal of Cancer",

issn = "0020-7136",

publisher = "Wiley-Liss Inc.",

number = "SUPPL. 3",

}

TY - JOUR

T1 - CA125 in the monitoring of response to chemotherapy of ovarian carcinoma

AU - Quaranta, M.

AU - Lorusso, V.

AU - Coviello, M.

AU - Micelli, G.

AU - Casamassima, A.

PY - 1988

Y1 - 1988

N2 - CA125 serum levels were assessed in 23 patients undergoing chemotherapy for advanced epithelial ovarian carcinoma (EOC). Rising, falling and unchanged levels correlated with disease in 21 out of 23 (95%) cases. Ten out of 11 patients who showed objective response to chemotherapy had a decrease in antigen levels. Two out of 3 patients with stable disease had unchanged values. Progression was always associated with rising levels. CA125 is a reliable marker for monitoring response to chemotherapy in advanced epithelial ovarian carcinoma.

AB - CA125 serum levels were assessed in 23 patients undergoing chemotherapy for advanced epithelial ovarian carcinoma (EOC). Rising, falling and unchanged levels correlated with disease in 21 out of 23 (95%) cases. Ten out of 11 patients who showed objective response to chemotherapy had a decrease in antigen levels. Two out of 3 patients with stable disease had unchanged values. Progression was always associated with rising levels. CA125 is a reliable marker for monitoring response to chemotherapy in advanced epithelial ovarian carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=0024192357&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024192357&partnerID=8YFLogxK

M3 - Article

C2 - 3209302

VL - 42

SP - 68

EP - 70

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - SUPPL. 3

ER -